Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB26FATYX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,760
Award facts
- Contract value 100% obligated
- $8,760.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,760.21 to DMS Pharmaceutical Group Inc. for HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic immunosuppressant medication. The award, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its facility in Conshohocken, Pennsylvania.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to supply pharmaceutical products to Department of Defense military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 and extending through December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability to support the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FATYX?
SPE2DB26FATYX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FATYX worth?
The government has obligated $8,760 on SPE2DB26FATYX.
Is contract SPE2DB26FATYX an order under another contract?
Yes. SPE2DB26FATYX is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATYX competed?
The extent of competition for SPE2DB26FATYX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award